Medtronic plc (NYSE: MDT) reported fourth quarter 2024 earnings results today.
Worldwide revenue was $8.6 billion, up 0.5% on a reported basis and 5.4% on an organic basis.
Net income decreased 45% to $654 million and EPS fell 44% to $0.49 compared to last year. Adjusted EPS decreased 7% to $1.46.
For fiscal year 2025, the company expects organic revenue growth of 4-5%. Adjusted EPS is expected to range between $5.40-5.50.